OPIANT PHARMACEUTICALS, INC. Uncategorized Contracts & Agreements

45 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2022
Director Agreement, effective March 18, 2021, by and between Opiant Pharmaceuticals, Inc. and Dr. Lorianne Masuoka
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2021
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2021
Amendment of Solicitation/Modification of Contract
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2020
Description of the Registrant's Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2020
Open Market Sale AgreementSM, dated November 14, 2019, by and between Opiant Pharmaceuticals, Inc. and Jefferies LLC
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2019
Director Agreement, effective October 29, 2018, by and between Opiant Pharmaceuticals, Inc. and Craig A. Collard
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2018
Director Agreement, effective June 12, 2018, by and between Opiant Pharmaceuticals, Inc. and Richard Daly
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2018
Supplemental Engagement Letter, dated September 8, 2017, by and between the Company and Torreya Partners (Europe) LLP
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Offer Letter, dated August 29, 2017, by and between the Company and David OToole
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
THIRD AMENDMENT TO SENIOR ADVISOR AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
AMENDMENT TO AMENDED AND RESTATED CONSULTINGAGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
SecondAmendment to Senior Advisor Agreement
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
First Amendment toSenior Advisor Agreement
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
Senior Advisor Agreement
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
THIRD AMENDMENT TO SENIOR ADVISOR AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2017
OPIANT PHARMACEUTICALS, INC. DIRECTOR AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Torreya Partners (Europe) LLP isauthorised and regulated by the Financial Conduct Authority.
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
REGULATORY AND STRATEGIC ADVISOR CONSULTANCYAGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2016
AMENDED AND RESTATED INTEREST AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Lightlake Therapeutics Inc. 96-98 Baker Street First Floor London, W1U6TJ United Kingdom Phone: 44 20 3617 8739 www.lightlaketherapeutics.com
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Lightlake Therapeutics Inc. 96-98 Baker Street First Floor London,W1U 6TJ United Kingdom Phone: 44 20 3617 8739 www.lightlaketherapeutics.com
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
AMENDED AND RESTATEDINTEREST AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2016
Lightlake Therapeutics Inc. 96-98 Baker Street First Floor London, W1U6TJ United Kingdom Phone: 44 20 3617 8739 www.lightlaketherapeutics.com
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Lightlake Therapeutics Inc. 96-98 Baker Street First Floor London,W1U 6TJ United Kingdom Phone: 44 20 3617 8739 www.lightlaketherapeutics.com
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
11770 Bernardo Plaza Court, Suite 353 San Diego, CA 92128 Phone: 858 ###-###-#### Facsimile ###-###-#### Confidential
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NY
2016
AMENDED AND RESTATED MATERIAL TRANSFER, OPTION AND RESEARCHLICENSE AGREEMENT between OPIANT PHARMACEUTICALS, INC. and AEGIS THERAPEUTICS, LLC
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
OPIANT PHARMACEUTICALS, INC. DIRECTOR AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
OPIANTPHARMACEUTICALS, LNC. DIRECTORAGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Third Amendment to Executive Letter ofAppointment
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
Third Amendment to Executive Letter ofReappointment
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2016
LIGHTLAKETHERAPEUTICS INC. 445Park Avenue, 9th Floor NewYork, NY STOCKOPTION GRANT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
LIGHTLAKETHERAPEUTICS INC. 445Park Avenue, 9th Floor NewYork, NY STOCKOPTION GRANT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
LIGHTLAKETHERAPEUTICS INC. 445Park Avenue, 9th Floor NewYork, NY STOCKOPTION GRANT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
MATERIAL TRANSFER, OPTION AND RESEARCHLICENSE AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
ConfidentialTreatment Requested by Lightlake Therapeutics Inc. IRS EmployerIdentification No. 46 ###-###-#### Confidentialtreatment requested with respect to certain portions...
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
MATERIAL TRANSFER, OPTION AND RESEARCHLICENSE AGREEMENT
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2015
Second Amendment to Executive Letterof Appointment
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2014
Second Amendment to Executive Letterof Reappointment
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
NV
2014
Director Agreement
OPIANT PHARMACEUTICALS, INC.
Pharmaceuticals
2013